A critical discovery in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently disabled in various forms of cancer, causing uncontrolled https://wearethelist.com/story24154516/mini-antibodies-revive-p53-the-potential-hope-for-tumor-treatment